Frequency of & Risk Factors for Depression among Participants in the Swiss HIV Cohort Study (SHCS)

We studied the incidence and prevalence of, and co-factors for depression in the Swiss HIV Cohort Study.

Depression-specific items were introduced in 2010 and prospectively collected at semiannual cohort visits. Clinical, laboratory and behavioral co-factors of incident depression among participants free of depression at the first two visits in 2010 or thereafter were analyzed with Poisson regression. Cumulative prevalence of depression at the last visit was analyzed with logistic regression.

Among 4,422 participants without a history of psychiatric disorders or depression at baseline, 360 developed depression during 9,348 person-years (PY) of follow-up, resulting in an incidence rate of 3.9 per 100 PY. Cumulative prevalence of depression during follow-up was recorded for 1,937/6,756 (28.7%) participants. Incidence and cumulative prevalence were higher in injection drug users (IDU) and women. Older age, preserved work ability and higher physical activity were associated with less depression episodes. Mortality based upon 193 deaths over 20,102 PY was higher among male IDU, female IDU and white heterosexual men compared to white heterosexual women and homosexual men. Compared to participants free of depression, mortality was slightly elevated among participants with a history of depression. Suicides (n = 18) did not differ between HIV transmission groups, but were more frequent among participants with a prior diagnosis of depression.

Depression is a frequent co-morbidity among HIV-infected persons, and thus an important focus of care.

Below:  The top panel shows the incidence of depression among 4,422 individuals (360 events during 9,348 person years) without depression at the first two visits since January 2010 and cumulative prevalence of depression at the last follow-up among 6756 persons seen since January 2010 (1937 events).

The bottom panel displays the incidence of depression stratified by risk and age groups. Tests for trend across age groups were MSM: P = 0.004, heterosexual men: P = 0.007, and women: P = 0.53. Abbreviations: PY, person years; MSM, men who have sex with men; HET, heterosexually infected person; IDU, injection drug user.

Full article at: http://goo.gl/BxqYdK

By:

Alexia Anagnostopoulos, Bruno Ledergerber, Rainer Weber

Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland

René Jaccard

Independent Researcher, HIV Practitioner, Zurich, Switzerland

Susy Ann Shaw

Division of Infectious Diseases, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

Marcel Stoeckle

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland

Enos Bernasconi

Division of Infectious Diseases, Regional Hospital Lugano, Lugano, Switzerland

Jürgen Barth

Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland

Alexandra Calmy

Division of Infectious Diseases, Geneva University Hospital, Geneva, Switzerland

Alexandre Berney

Psychiatry Liaison Service, Lausanne University Hospital, Lausanne, Switzerland

Josef Jenewein

Department of Psychiatry and Psychotherapy, University Hospital of Zurich, Zurich, Switzerland

More at:  https://twitter.com/hiv_insight